Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability: Influencing Factors

Bioavailability: Influencing Factors

Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...

Bioavailability: Overview

Bioavailability: Overview

Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...

Bioavailability: Overview

Bioavailability: Overview

Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...

Factors Influencing Bioavailability: First-Pass Elimination

Factors Influencing Bioavailability: First-Pass Elimination

When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Using 6S-5-methyltetrahydrofolate instead of folic acid in prenatal multivitamin reduces unmetabolized folic acid concentrations in the mother-fetus dyad: a 24-week randomized controlled trial.

Frontiers in nutrition·2026

Same author

Erratum: Pilot trials of oral betaine in participants with non-alcoholic fatty liver disease and elevated alanine aminotransferase.

Hepatology (Baltimore, Md.)·2025

Same author

Pilot trials of oral betaine in participants with metabolic dysfunction-associated steatotic liver disease and elevated alanine aminotransferase.

Hepatology (Baltimore, Md.)·2025

Same author

Folic Acid and Methyltetrahydrofolate Supplementation in the <i>Mthfr</i> Mouse Model with Hepatic Steatosis.

Nutrients·2025

Same author

Betaine for the prevention and treatment of insulin resistance and fatty liver in a high-fat dietary model of insulin resistance in C57BL mice.

Frontiers in nutrition·2024

Same author

Folate Deficiency and/or the Genetic Variant Mthfr<sup>677C >T</sup> Can Drive Hepatic Fibrosis or Steatosis in Mice, in a Sex-Specific Manner.

Molecular nutrition & food research·2024

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Folate bioavailability: implications for establishing dietary recommendations and optimizing status.

Marie A Caudill¹

¹Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA. mac379@cornell.edu

The American Journal of Clinical Nutrition

|March 12, 2010

Summary

This summary is machine-generated.

Folic acid bioavailability varies significantly based on diet and individual factors, making a single estimate inaccurate. Understanding these differences is crucial for optimal folate intake and health.

More Related Videos

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability

Published on: April 28, 2022

Related Experiment Videos

Last Updated: Jun 15, 2026

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability

The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability

Published on: April 28, 2022

Area of Science:

Nutritional Biochemistry
Human Physiology

Background:

Folic acid fortification in the US food supply has increased global interest in folate bioavailability.
Folate plays a critical role in various health outcomes, necessitating accurate bioavailability assessments.

Purpose of the Study:

To summarize and integrate folate bioavailability estimates using whole-diet approaches.
To highlight genetic, ethnic-racial, and sex influences on postabsorptive folate bioavailability.
To discuss the adequacy of the US Recommended Dietary Allowance for folate in specific subpopulations.

Main Methods:

Review and synthesis of studies employing whole-diet methodologies to estimate folate bioavailability.
Analysis of factors influencing folate absorption and postabsorptive utilization.
Examination of existing data on genetic, ethnic-racial, and sex variations in folate metabolism.

Main Results:

Food folate bioavailability is generally lower than folic acid bioavailability, with significant variability.
Dietary patterns and individual host factors (genetics, ethnicity-race, sex) substantially modify folate bioavailability.
Existing bioavailability figures may not accurately represent folate status across diverse populations and dietary contexts.

Conclusions:

A single bioavailability value for food folate is insufficient due to complex diet-host interactions.
Individual variability, including genetics and ethnicity-race, significantly impacts folate bioavailability.
The adequacy of the US folate Recommended Dietary Allowance may need re-evaluation for certain subpopulations.